(Q48230458)

9 February 2018

title

Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques. (English)

1 reference

9 February 2018

0 references

Bernstein HG

1

1 reference

9 February 2018

Ansorge S

2

1 reference

9 February 2018

Riederer P

3

1 reference

9 February 2018

Reiser M

4

1 reference

9 February 2018

Frölich L

5

1 reference

9 February 2018

Bogerts B

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

9 February 2018

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

9 February 2018

volume

263

1 reference

9 February 2018

page(s)

161-164

1 reference

9 February 2018

issue

2-3

1 reference

9 February 2018

Increased immunostaining for L-ornithine decarboxylase occurs in neocortical neurons of Alzheimer's disease patients.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

Insulin- and glucagonlike peptides in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

Degradation of insulin and glucagon in developing rat kidney: immunolocalization of insulin-glucagon-specific protease and quantitative estimation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

Electron-microscopic observation of the nucleus basilis of Meynert in human autopsy cases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

Atrial natriuretic peptide (ANP) is a high-affinity substrate for rat insulin-degrading enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

Identification of gamma-endorphin-generating enzyme as insulin-degrading enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900135-4

7 January 2021

10.1016/S0304-3940(99)00135-4

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

10213160

1 reference

9 February 2018